Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy.
Coelho T, Marques W Jr, Dasgupta NR, Chao CC, Parman Y, França MC Jr, Guo YC, Wixner J, Ro LS, Calandra CR, Kowacs PA, Berk JL, Obici L, Barroso FA, Weiler M, Conceição I, Jung SW, Buchele G, Brambatti M, Chen J, Hughes SG, Schneider E, Viney NJ, Masri A, Gertz MR, Ando Y, Gillmore JD, Khella S, Dyck PJB, Waddington Cruz M; NEURO-TTRansform Investigators.
JAMA. 2023 Oct 17;330(15):1448-1458. doi: 10.1001/jama.2023.18688.
Vascular Cognitive Impairment and Dementia.
Chang Wong E, Chang Chui H.
Continuum (Minneap Minn). 2022 Jun 1;28(3):750-780. doi: 10.1212/CON.0000000000001124.
Transthyretin cardiac amyloidosis.
Tomoaia R, Beyer R, Manole S, Chirilă A, Dădârlat-Pop A, Minciună IA, Pop D.
Med Pharm Rep. 2021 Aug;94(Suppl No 1):S11-S14. doi: 10.15386/mpr-2219. Epub 2021 Aug 10.
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey.
González-Moreno J, Dispenzieri A, Grogan M, Coelho T, Tournev I, Waddington-Cruz M, Wixner J, Diemberger I, Garcia-Pavia P, Chapman D, Gupta P, Glass O, Amass L; THAOS investigators.
Cardiol Ther. 2024 Mar;13(1):117-135. doi: 10.1007/s40119-023-00344-3. Epub 2023 Dec 20.
ATTR Epidemiology, Genetics, and Prognostic Factors.
Obi CA, Mostertz WC, Griffin JM, Judge DP.
Methodist Debakey Cardiovasc J. 2022 Mar 14;18(2):17-26. doi: 10.14797/mdcvj.1066. eCollection 2022.
Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy.
Poli L, Labella B, Cotti Piccinelli S, Caria F, Risi B, Damioli S, Padovani A, Filosto M.
Front Neurol. 2023 Oct 5;14:1242815. doi: 10.3389/fneur.2023.1242815. eCollection 2023.
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Gentile L, Coelho T, Dispenzieri A, Conceição I, Waddington-Cruz M, Kristen A, Wixner J, Diemberger I, Gonzalez-Moreno J, Cariou E, Maurer MS, Planté-Bordeneuve V, Garcia-Pavia P, Tournev I, Gonzalez-Costello J, Duarte AG, Grogan M, Mazzeo A, Chapman D, Gupta P, Glass O, Amass L; THAOS investigators.
Orphanet J Rare Dis. 2023 Nov 10;18(1):350. doi: 10.1186/s13023-023-02962-5.
Peripheral nerve amyloidosis.
Reilly MM, Staunton H.
Brain Pathol. 1996 Apr;6(2):163-77. doi: 10.1111/j.1750-3639.1996.tb00798.x.
Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA, Witzigmann D, Chen S, Cullis PR, van der Meel R.
Acc Chem Res. 2019 Sep 17;52(9):2435-2444. doi: 10.1021/acs.accounts.9b00368. Epub 2019 Aug 9.
Secondary cardiac amyloidosis in a patient with mixed connective tissue disease: A case report.
Khanal UP, Ghimire P, Shahi T, Dhakal TR, Jha S.
Clin Case Rep. 2023 Jul 6;11(7):e07669. doi: 10.1002/ccr3.7669. eCollection 2023 Jul.
